Abstract: A two-component adhesive includes agent A containing an epoxy resin and agent B containing a polymer having a crosslinkable silicon group and an epoxy resin curing agent, wherein agent A and/or agent B contain(s) a core-shell rubber particle, and a condensation catalyst for the crosslinkable silicon group. Another adhesive contains an epoxy resin, a core-shell rubber particle, a polymer having a crosslinkable silicon group, an epoxy resin curing agent, and a condensation catalyst for the crosslinkable silicon group, wherein a cured product of the adhesive has a breaking strength (tensile strength at rupture) of 5 MPa or more and an elongation at break (elongation at rupture) of 30% or more, and has storage elastic moduli at 1 Hz in tensile mode of 100 to 1000 MPa at 20° C. and 50 to 1000 MPa at 80° C.

Abstract: Provided is a novel curable composition that is a two-pack type curable composition that includes an epoxy resin and a crosslinkable silicon group-containing organic polymer, excels in storage stability, and does not experience curing delays, an increase in viscosity of the base material, or the deterioration of the base material such as gelation or the deposition of insoluble material. Also provided is a novel curable composition that excels in storage stability even when water is added to improve deep portion curability. A two-pack type epoxy composition according to the present invention contains: a base material that includes (A) an epoxy resin, (B) a compound having an Si—F bond, and (C) an alkoxysilane not having at least one group selected from the group consisting of a primary amino group, a secondary amino group, and a mercapto group; and a curing agent that includes (D) a crosslinkable silicon group-containing organic polymer, and (E) a tertiary amine compound.

Abstract: Provided is a novel curable composition that is a two-pack type curable composition that includes an epoxy resin and a crosslinkable silicon group-containing organic polymer, excels in storage stability, and does not experience curing delays, an increase in viscosity of the base material, or the deterioration of the base material such as gelation or the deposition of insoluble material. Also provided is a novel curable composition that excels in storage stability even when water is added to improve deep portion curability. A two-pack type epoxy composition according to the present invention contains: a base material that includes (A) an epoxy resin, (B) a compound having an Si—F bond, and (C) an alkoxysilane not having at least one group selected from the group consisting of a primary amino group, a secondary amino group, and a mercapto group; and a curing agent that includes (D) a crosslinkable silicon group-containing organic polymer, and (E) a tertiary amine compound.

Abstract: The present invention relates to a process for production of a steroid compound having a partial structure represented by Formula (2) by oxidizing a steroid compound having a partial structure represented by Formula (1), without the need of any special apparatus, in a safe and economical manner, with less adverse affect on environment, in a simple and high efficient manner. Specifically, the invention relates to a process for producing a steroid compound having a partial structure of ring A and ring B of the steroid skeleton represented by Formula (2): wherein R represents a hydrogen atom or C1-6 alkyl group, comprising the step of reacting a steroid compound having a partial structure of ring A and ring B of the steroid skeleton represented by Formula (1): wherein R is the same as above; with a catalytic amount of copper halide in the presence of oxygen.

Abstract: An image forming apparatus capable of forming wide images, includes: an exposing unit having a plurality of LED (light-emitting diode) heads arranged alternately in a main scanning direction, in which the resolution of an LED row formed in at least one of the plurality of LED heads is higher than the resolution of image data in a main scanning direction; and a lighting control unit that controls to turn on or turn off dots in the LED row such that the exposing position of a photoconductive drum is moved in the unit of dots of the high resolution LED row.

Abstract: The present invention relates to a process for production of a steroid compound having a partial structure represented by Formula (2) by oxidizing a steroid compound having a partial structure represented by Formula (1), without the need of any special apparatus, in a safe and economical manner, with less adverse affect on environment, in a simple and high efficient manner. Specifically, the invention relates to a process for producing a steroid compound having a partial structure of ring A and ring B of the steroid skeleton represented by Formula (2): wherein R represents a hydrogen atom or C1-6 alkyl group, comprising the step of reacting a steroid compound having a partial structure of ring A and ring B of the steroid skeleton represented by Formula (1): wherein R is the same as above; with a catalytic amount of copper halide in the presence of oxygen.

Abstract: An image forming apparatus utilizing a light-emitting diode (LED). The image forming apparatus includes: an LED head including an LED array that has a plurality of dots, in which a resolution a (dpi) of the LED array and a resolution b (dpi) in a main scanning direction at an image data exposure satisfy a relation: a>b (a being an integral multiple of b); and a lighting control unit that performs a lighting control for the LED head such that main dots used for an exposure are turned on in every {(a/b)?1} dots.

Abstract: An image forming device, comprising: a cylindrical rotatable photoreceptor rotatably supported by an apparatus body; an exposure device in which plural exposure heads which expose an outer circumferential surface of the rotatable photoreceptor are disposed in a common housing in such a manner that exposure sections thereof are consecutively positioned; and a supporting unit having a position adjusting mechanism for adjusting a posture of the exposure device in at least two locations, which supports the exposure device and which is fixed on the apparatus body.

Abstract: An image forming apparatus capable of forming wide images, includes: an exposing unit having a plurality of LED (light-emitting diode) heads arranged alternately in a main scanning direction, in which the resolution of an LED row formed in at least one of the plurality of LED heads is higher than the resolution of image data in a main scanning direction; and a lighting control unit that controls to turn on or turn off dots in the LED row such that the exposing position of a photoconductive drum is moved in the unit of dots of the high resolution LED row.

Abstract: An image forming apparatus utilizing a light-emitting diode (LED). The image forming apparatus includes: an LED head including an LED array that has a plurality of dots, in which a resolution a (dpi) of the LED array and a resolution b (dpi) in a main scanning direction at an image data exposure satisfy a relation: a>b (a being an integral multiple of b); and a lighting control unit that performs a lighting control for the LED head such that main dots used for an exposure are turned on in every {(a/b)?1} dots.

Abstract: An image forming device, comprising: a cylindrical rotatable photoreceptor rotatably supported by an apparatus body; an exposure device in which plural exposure heads which expose an outer circumferential surface of the rotatable photoreceptor are disposed in a common housing in such a manner that exposure sections thereof are consecutively positioned; and a supporting unit having a position adjusting mechanism for adjusting a posture of the exposure device in at least two locations, which supports the exposure device and which is fixed on the apparatus body.

Abstract: A method of producing 3-alkoxy-1,3,5(10)-triene-6-one-steroid derivatives having, in the steroid skeleton thereof, a partial structure of A- and B-rings represented by formula (2): (wherein R represents an alkyl group, a cycloalkyl group, an alkenyl group, or an aralkyl group), including reacting a 19-norsteroid derivative having, in the steroid skeleton thereof, a partial structure of A- and B-rings represented by formula (1): with an alcohol represented by ROH (wherein R has the same meaning as defined above) and iodine in the absence of a rare earth compound catalyst. According to the method of the present invention, 3-alkoxy-1,3,5(10)-triene-6-one-steroids can be selectively produced from 19-norsteroides through a single reaction step without employment of a special catalyst.

Abstract: A method of producing 3-alkoxy-1,3,5(10)-triene-6-one-steroid derivatives having, in the steroid skeleton thereof, a partial structure of A- and B-rings represented by formula (2): 1

Abstract: The invention relates to novel uracil derivatives having excellent inhibiting effects on human derived thymidine phosphorylates and anti-tumor activity. The pharmaceutical compositions, anti-tumor potentiators and antitumor agents containing such novel compounds, and a process for their preparation and use are described.

Abstract: The invention relates to novel uracil derivatives having excellent inhibiting effects of human derived thymidine phosphorylase and anti-tumor activity. The pharmaceutical compositions, anti-tumor potentiators, antitumor agents containing such novel compounds, and a process for their preparation and use is described.

Abstract: This invention relates to a thiazolidinedione derivative represented by the following formula (1): ##STR1## wherein R.sup.1 and R.sup.2 individually represent H, a halogen atom, or a halogen-substituted or -unsubstituted lower alkyl or alkoxy group, and R.sup.1 and R.sup.2 may be coupled together to form a ring of an alkylenedioxy chain, X represents a nitrogen atom or a CH group, A represents a substituted or unsubstituted imidazolidinone, pyrrolidinone, imidazole or pyrazole ring, or a salt thereof; and a pharmaceutical composition containing the thiazolidinedione derivative or a salt thereof. The above compound has excellent blood sugar-lowering action and blood lipid-lowering action and is useful as a therapeutic agent for diabetes.

Abstract: The invention relates to novel uracil derivatives having excellent inhibiting effects of human derived thymidine phosphorylase and anti-tumor activity. The pharmaceutical compositions, anti-tumor potentiators, antitumor agents containing such novel compounds, and a process for their preparation and use is described.

Abstract: A thiazolidine derivative represented by the following formula (1): ##STR1## X represents a carbon atom or nitrogen atom, Y represents an oxygen atom or an imino group; A and B individually represent a lower alkylene group, m stands for 0 or 1, and a method of treatment of diabetes by administration of the compound.

Abstract: An oxazolidine derivative represented by the formula (I) ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are H, optionally halogenated alkyl, optionally halogenated alkoxy, OH, halo, NO.sub.2, amino optionally having acetyl or alkyl, COOH, alkoxycarbonyl, CN, alkanoyl, 2-oxazolyl, or R.sup.1 and R.sup.2 may be combined with each other to represent --(CH.sub.2).sub.p -- or --O(CH.sub.2).sub.q O-- (p is 3-5, q is 1-3) to form a ring, m and n are each 0 or 1, R.sup.4 and R.sup.5 are H or alkyl, X is C or N, Y is CH.sub.2 OH, CHO or COOR.sup.6 (R.sup.6 is alkyl, benzyl or H), A is alkylene, carbonyl or sulfonyl, B is alkylene, E is alkylene which may be substituted with halo or is alkenylene, Z is O or S, except for a compound wherein n is 0, m is 1 and Y is CH.sub.2 OH, and except for a compound wherein n is 0, Y is COOR.sup.6 (R.sup.

Abstract: Disclosed are a 1-phenylpyrrolidone derivative having optical activity and represented by the formula (I) ##STR1## wherein R represents an optionally substituted optically active .alpha.-phenylethylamino group, a 1-phenylpyrrolidone derivative represented by the formula (I-a) ##STR2## and processes for preparing the 1-phenylpyrrolidone derivatives represented by the formulas (I) and (I-a), respectively.